Solara Active Pharma Sciences Ltd announced the successful completion EU-GMP Inspection, carried out jointly by the SUKL, Ministry of Health of the Czech Republic and INFARMED, Portugal at the multi-product manufacturing facility at Cuddalore.
Solara Active Pharma Sciences Ltd today announced that its new state-of-the-art multipurpose API manufacturing facility at Visakhapatnam, Andhra Pradesh completed successfully the inspection carried out by the US FDA.
Solara Active Pharma Sciences Limited has successfully completed the inspection carried out by the World Health Organization at its Cuddalore facility, Tamil Nadu between January 23 – 26, 2023.
Solara Active Pharma Sciences Ltd ha announced that its new state of the art multipurpose API manufacturing facility at Vishakhapatnam, Andhra Pradesh, had received Certificate of Suitability approval for the manufacture of Ibuprofen API, from EDQM.